0
May 01, 2009
Quetiapine
Expires May 31, 2015
+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
Which of the following receptor-binding properties of quetiapine may explain its low rates of extrapyramidal side effects (EPS) and lack of prolactin elevation?
2.
In regard to quetiapine’s adverse-effect profile, a recent 8-week clinical trial of quetiapine found that the most commonly reported side effect was
3.
In comparisons of weight gain with quetiapine versus olanzapine, risperidone, perphenazine, and ziprasidone in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) phase I study, quetiapine